381 related articles for article (PubMed ID: 19776291)
1. Association of testicular germ cell tumor with polymorphisms in estrogen receptor and steroid metabolism genes.
Ferlin A; Ganz F; Pengo M; Selice R; Frigo AC; Foresta C
Endocr Relat Cancer; 2010 Mar; 17(1):17-25. PubMed ID: 19776291
[TBL] [Abstract][Full Text] [Related]
2. Genetic variation in hormone metabolizing genes and risk of testicular germ cell tumors.
Figueroa JD; Sakoda LC; Graubard BI; Chanock S; Rubertone MV; Erickson RL; McGlynn KA
Cancer Causes Control; 2008 Nov; 19(9):917-29. PubMed ID: 18415690
[TBL] [Abstract][Full Text] [Related]
3. Effect modification of endocrine disruptors and testicular germ cell tumour risk by hormone-metabolizing genes.
Chia VM; Li Y; Quraishi SM; Graubard BI; Figueroa JD; Weber JP; Chanock SJ; Rubertone MV; Erickson RL; McGlynn KA
Int J Androl; 2010 Aug; 33(4):588-96. PubMed ID: 19627379
[TBL] [Abstract][Full Text] [Related]
4. Gene variations in sex hormone pathways and the risk of testicular germ cell tumour: a case-parent triad study in a Norwegian-Swedish population.
Kristiansen W; Andreassen KE; Karlsson R; Aschim EL; Bremnes RM; Dahl O; Fosså SD; Klepp O; Langberg CW; Solberg A; Tretli S; Adami HO; Wiklund F; Grotmol T; Haugen TB
Hum Reprod; 2012 May; 27(5):1525-35. PubMed ID: 22402210
[TBL] [Abstract][Full Text] [Related]
5. Estrogen sulfation genes, hormone replacement therapy, and endometrial cancer risk.
Rebbeck TR; Troxel AB; Wang Y; Walker AH; Panossian S; Gallagher S; Shatalova EG; Blanchard R; Bunin G; DeMichele A; Rubin SC; Baumgarten M; Berlin M; Schinnar R; Berlin JA; Strom BL
J Natl Cancer Inst; 2006 Sep; 98(18):1311-20. PubMed ID: 16985250
[TBL] [Abstract][Full Text] [Related]
6. Expression of estrogenicity genes in a lineage cell culture model of human breast cancer progression.
Fu J; Weise AM; Falany JL; Falany CN; Thibodeau BJ; Miller FR; Kocarek TA; Runge-Morris M
Breast Cancer Res Treat; 2010 Feb; 120(1):35-45. PubMed ID: 19308726
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in genes involved in the estrogen pathway and mammographic density.
Dumas I; Diorio C
BMC Cancer; 2010 Nov; 10():636. PubMed ID: 21092186
[TBL] [Abstract][Full Text] [Related]
8. Cognitive functioning and sex steroid hormone gene polymorphisms in women at midlife.
Kravitz HM; Meyer PM; Seeman TE; Greendale GA; Sowers MR
Am J Med; 2006 Sep; 119(9 Suppl 1):S94-S102. PubMed ID: 16949394
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of SNP in estrogen-metabolizing enzymes for ovarian, endometrial, and breast cancers in Novosibirsk, Russia.
Gulyaeva LF; Mikhailova ON; PustyInyak VO; Kim IV; Gerasimov AV; Krasilnikov SE; Filipenko ML; Pechkovsky EV
Adv Exp Med Biol; 2008; 617():359-66. PubMed ID: 18497059
[TBL] [Abstract][Full Text] [Related]
10. Sex steroid metabolism polymorphisms and mammographic density in pre- and early perimenopausal women.
Crandall CJ; Sehl ME; Crawford SL; Gold EB; Habel LA; Butler LM; Sowers MR; Greendale GA; Sinsheimer JS
Breast Cancer Res; 2009; 11(4):R51. PubMed ID: 19630952
[TBL] [Abstract][Full Text] [Related]
11. Association of genetic polymorphisms in ESR2, HSD17B1, ABCB1, and SHBG genes with colorectal cancer risk.
Sainz J; Rudolph A; Hein R; Hoffmeister M; Buch S; von Schönfels W; Hampe J; Schafmayer C; Völzke H; Frank B; Brenner H; Försti A; Hemminki K; Chang-Claude J
Endocr Relat Cancer; 2011 Apr; 18(2):265-76. PubMed ID: 21317201
[TBL] [Abstract][Full Text] [Related]
12. CYP1A1, CYP3A5 and CYP3A7 polymorphisms and testicular cancer susceptibility.
Kristiansen W; Haugen TB; Witczak O; Andersen JM; Fosså SD; Aschim EL
Int J Androl; 2011 Feb; 34(1):77-83. PubMed ID: 20345875
[TBL] [Abstract][Full Text] [Related]
13. Interactions between genetic polymorphism of cytochrome P450-1B1, sulfotransferase 1A1, catechol-o-methyltransferase and tobacco exposure in breast cancer risk.
Saintot M; Malaveille C; Hautefeuille A; Gerber M
Int J Cancer; 2003 Nov; 107(4):652-7. PubMed ID: 14520706
[TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphisms in estrogen-metabolizing genes and breast cancer survival.
Long JR; Cai Q; Shu XO; Cai H; Gao YT; Zheng W
Pharmacogenet Genomics; 2007 May; 17(5):331-8. PubMed ID: 17429315
[TBL] [Abstract][Full Text] [Related]
15. Molecular epidemiology of sporadic breast cancer. The role of polymorphic genes involved in oestrogen biosynthesis and metabolism.
Mitrunen K; Hirvonen A
Mutat Res; 2003 Sep; 544(1):9-41. PubMed ID: 12888106
[TBL] [Abstract][Full Text] [Related]
16. Genetic variants of GPER/GPR30, a novel estrogen-related G protein receptor, are associated with human seminoma.
Chevalier N; Paul-Bellon R; Camparo P; Michiels JF; Chevallier D; Fénichel P
Int J Mol Sci; 2014 Jan; 15(1):1574-89. PubMed ID: 24451139
[TBL] [Abstract][Full Text] [Related]
17. CYP1A1, SULT1A1, and SULT1E1 polymorphisms are risk factors for endometrial cancer susceptibility.
Hirata H; Hinoda Y; Okayama N; Suehiro Y; Kawamoto K; Kikuno N; Rabban JT; Chen LM; Dahiya R
Cancer; 2008 May; 112(9):1964-73. PubMed ID: 18318428
[TBL] [Abstract][Full Text] [Related]
18. Effect of tumor necrosis factor-alpha on estrogen metabolism and endometrial cells: potential physiological and pathological relevance.
Salama SA; Kamel MW; Diaz-Arrastia CR; Xu X; Veenstra TD; Salih S; Botting SK; Kumar R
J Clin Endocrinol Metab; 2009 Jan; 94(1):285-93. PubMed ID: 18957495
[TBL] [Abstract][Full Text] [Related]
19. Estrogen pathway polymorphisms and mammographic density.
Dumas I; Diorio C
Anticancer Res; 2011 Dec; 31(12):4369-86. PubMed ID: 22199302
[TBL] [Abstract][Full Text] [Related]
20. Genetic variation in AKT1, PTEN and the 8q24 locus, and the risk of testicular germ cell tumor.
Andreassen KE; Kristiansen W; Karlsson R; Aschim EL; Dahl O; Fosså SD; Adami HO; Wiklund F; Haugen TB; Grotmol T
Hum Reprod; 2013 Jul; 28(7):1995-2002. PubMed ID: 23639623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
